# Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

> **NCT00156858** · NA · UNKNOWN · sponsor: **Alberta Health services** · enrollment: 200 (estimated)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **DRUG:** intravenous busulfan

## Key facts

- **NCT ID:** NCT00156858
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2010-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156858, "Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00156858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*